XML 22 R10.htm IDEA: XBRL DOCUMENT v3.25.3
Revenue
 9 Months Ended
Sep. 30, 2025
Revenue Recognition [Abstract]  
Revenue Revenue
The following table presents the Company’s disaggregated revenue by offering type (in thousands):
 Three Months Ended
September 30,
 20252024
 
Total Net
Revenues
Percentage of
Total Net
Revenues
Total Net
Revenues
Percentage of
Total Net
Revenues
Patient Services revenue recognized at a point in time:
Direct products$690 1.9 %$685 1.9 %
Third-Party Payer products4,822 13.2 %3,917 11.1 %
Patient Services revenue recognized over time:
Direct rental services1,985 5.4 %1,923 5.4 %
Third-Party Payer rental services12,723 34.9 %12,277 34.8 %
Total Patient Services accounted for under ASC 60620,220 55.4 %18,802 53.2 %
Device Solutions revenue recognized at a point in time:
Products4,100 11.2 %4,731 13.4 %
Services
3,379 9.3 %2,575 7.3 %
Device Solutions revenue recognized over time:
Services
1,263 3.5 %1,841 5.2 %
Total Device Solutions accounted for under ASC 6068,742 24.0 %9,147 25.9 %
Total Revenue Accounted for under ASC 60628,962 79.4 %27,949 79.1 %
Patient Services lease revenue
2,144 5.9 %1,978 5.6 %
Device Solutions lease revenue
5,382 14.8 %5,393 15.3 %
Total Revenue accounted for under ASC 842, Leases7,526 20.6 %7,371 20.9 %
Total Net Revenue$36,488 100.0 %$35,320100.0 %
 Nine Months Ended
September 30,
 20252024
 
Total Net
Revenues
Percentage of
Total Net
Revenues
Total Net
Revenues
Percentage of
Total Net
Revenues
Patient Services revenue recognized at a point in time:
Direct products$1,979 1.8 %$2,030 2.0 %
Third-Party Payer products12,880 12.0 %11,182 11.1 %
Patient Services revenue recognized over time:
Direct rental services5,834 5.4 %5,724 5.7 %
Third-Party Payer rental services37,522 35.0 %35,144 34.8 %
Total Patient Services accounted for under ASC 60658,215 54.3 %54,080 53.5 %
Device Solutions revenue recognized at a point in time:
Products12,567 11.7 %12,886 12.8 %
Services8,463 7.9 %7,442 7.4 %
Device Solutions revenue recognized over time:
Services4,866 4.5 %5,850 5.8 %
Total Device Solutions accounted for under ASC 60625,896 24.2 %26,178 25.9 %
Total Revenue Accounted for under ASC 60684,111 78.5 %80,258 79.5 %
Patient Services Lease Revenue6,438 6.0 %5,537 5.5 %
Device Solutions Lease Revenue16,657 15.5 %15,218 15.1 %
Total Revenue accounted for under ASC 842, Leases23,095 21.5 %20,755 20.5 %
Total Net Revenue$107,206 100.0 %$101,013100.0 %

Contract Balances
(dollars in thousands)
As of September 30, 2025
As of December 31, 2024
$ Change
Accounts receivable, net$24,309 $21,155 $3,154 
Contract assets$1,625 $570 $1,055 
Contract liabilities$144 $— $144 
The change in contract assets during the nine months ended September 30, 2025 included $7.5 million of revenue recognized for which the payment is subject to conditions other than the passage of time, which was partially offset by $6.4 million of contract assets reclassified to accounts receivable as our right to consideration for these contract assets became unconditional. Contract assets are included in other current assets on the Company's condensed consolidated balance sheets.
The change in contract liabilities during the nine months ended September 30, 2025 was mainly due to the increase in the value of products and services billed to customers for which control of the products and services has not transferred to the customers. Contract liabilities are included in other current liabilities on the Company's condensed consolidated balance sheets.